{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Three point mutations in αSyn are associated with early-onset familial PD: A30P, E46K, and A53T. The paper links these mutations to altered fragmentation, conformation, and oligomer formation, which are implicated in neurodegeneration.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as involving proteasomal fragmentation, oligomer formation, and amyloidogenicity, which are directly tied to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses proteasome-mediated fragmentation and liposome interactions to assess αSyn processing, which models the cellular mechanisms of Lewy body formation and toxicity.",
          "judgment": "Yes",
          "reasoning": "The assays (proteasome activity, liposome association, and oligomer formation) are directly relevant to the disease mechanism described in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper compares wild-type and mutant αSyn, with proteasome activity and oligomer formation rates correlated to mutation severity.",
          "judgment": "No",
          "reasoning": "The abstract does not explicitly mention statistical replicates or control variant comparisons beyond wild-type, which are required for Sub-step 3a."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The rate of oligomer formation correlates with mutation severity, and proteasome fragmentation is observed for all mutations.",
          "judgment": "Max PS3_supporting",
          "reasoning": "The assay is accepted in the field, and the correlation between mutation severity and functional outcomes (oligomer formation) supports pathogenicity."
        }
      ],
      "type": "PS3_supporting",
      "description": "The A30P mutation correlates with increased oligomer formation and proteasome fragmentation, consistent with pathogenic mechanisms in PD."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The E46K mutation is associated with altered amyloidogenicity and proteasome processing, which are linked to PD pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as involving proteasomal fragmentation and oligomer formation, which are directly tied to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses proteasome-mediated fragmentation and liposome interactions to assess αSyn processing, which models the cellular mechanisms of Lewy body formation and toxicity.",
          "judgment": "Yes",
          "reasoning": "The assays (proteasome activity, liposome association, and oligomer formation) are directly relevant to the disease mechanism described in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper compares wild-type and mutant αSyn, with proteasome activity and oligomer formation rates correlated to mutation severity.",
          "judgment": "No",
          "reasoning": "The abstract does not explicitly mention statistical replicates or control variant comparisons beyond wild-type, which are required for Sub-step 3a."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The rate of oligomer formation correlates with mutation severity, and proteasome fragmentation is observed for all mutations.",
          "judgment": "Max PS3_supporting",
          "reasoning": "The assay is accepted in the field, and the correlation between mutation severity and functional outcomes (oligomer formation) supports pathogenicity."
        }
      ],
      "type": "PS3_supporting",
      "description": "The E46K mutation correlates with increased oligomer formation and proteasome fragmentation, consistent with pathogenic mechanisms in PD."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The A53T mutation is associated with altered amyloidogenicity and proteasome processing, which are linked to PD pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as involving proteasomal fragmentation and oligomer formation, which are directly tied to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses proteasome-mediated fragmentation and liposome interactions to assess αSyn processing, which models the cellular mechanisms of Lewy body formation and toxicity.",
          "judgment": "Yes",
          "reasoning": "The assays (proteasome activity, liposome association, and oligomer formation) are directly relevant to the disease mechanism described in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper compares wild-type and mutant αSyn, with proteasome activity and oligomer formation rates correlated to mutation severity.",
          "judgment": "No",
          "reasoning": "The abstract does not explicitly mention statistical replicates or control variant comparisons beyond wild-type, which are required for Sub-step 3a."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The rate of oligomer formation correlates with mutation severity, and proteasome fragmentation is observed for all mutations.",
          "judgment": "Max PS3_supporting",
          "reasoning": "The assay is accepted in the field, and the correlation between mutation severity and functional outcomes (oligomer formation) supports pathogenicity."
        }
      ],
      "type": "PS3_supporting",
      "description": "The A53T mutation correlates with increased oligomer formation and proteasome fragmentation, consistent with pathogenic mechanisms in PD."
    }
  ]
}